Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse

Despite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs, which constitute...

Full description

Saved in:
Bibliographic Details
Published inJournal of policy analysis and management Vol. 38; no. 1; pp. 181 - 209
Main Authors Grecu, Anca M., Dave, Dhaval M., Saffer, Henry
Format Journal Article
LanguageEnglish
Published United States Wiley Periodicals Inc 2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Despite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs, which constitute a key policy targeting access to non‐medical use of Rx drugs. Based on objective indicators of abuse as measured by substance abuse treatment admissions and mortality related to Rx drugs, estimates do not suggest any substantial effects of instituting an operational PDMP. We find, however, that mandatory‐access provisions, which raised PDMP utilization rates by actually requiring providers to query the PDMP prior to prescribing a controlled drug, are significantly associated with a reduction in Rx drug abuse. The effects are driven primarily by a reduction in opioid abuse, generally strongest among young adults (ages 18 to 24), and underscore important dynamics in the policy response. Robustness checks are consistent with a causal interpretation of these effects. We also assess potential spillovers of mandatory PDMPs on the use of other illicit drugs and find a complementary reduction in admissions related to cocaine and marijuana abuse.
AbstractList Despite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs, which constitute a key policy targeting access to non‐medical use of Rx drugs. Based on objective indicators of abuse as measured by substance abuse treatment admissions and mortality related to Rx drugs, estimates do not suggest any substantial effects of instituting an operational PDMP. We find, however, that mandatory‐access provisions, which raised PDMP utilization rates by actually requiring providers to query the PDMP prior to prescribing a controlled drug, are significantly associated with a reduction in Rx drug abuse. The effects are driven primarily by a reduction in opioid abuse, generally strongest among young adults (ages 18 to 24), and underscore important dynamics in the policy response. Robustness checks are consistent with a causal interpretation of these effects. We also assess potential spillovers of mandatory PDMPs on the use of other illicit drugs and find a complementary reduction in admissions related to cocaine and marijuana abuse.
Abstract Despite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs, which constitute a key policy targeting access to non‐medical use of Rx drugs. Based on objective indicators of abuse as measured by substance abuse treatment admissions and mortality related to Rx drugs, estimates do not suggest any substantial effects of instituting an operational PDMP. We find, however, that mandatory‐access provisions, which raised PDMP utilization rates by actually requiring providers to query the PDMP prior to prescribing a controlled drug, are significantly associated with a reduction in Rx drug abuse. The effects are driven primarily by a reduction in opioid abuse, generally strongest among young adults (ages 18 to 24), and underscore important dynamics in the policy response. Robustness checks are consistent with a causal interpretation of these effects. We also assess potential spillovers of mandatory PDMPs on the use of other illicit drugs and find a complementary reduction in admissions related to cocaine and marijuana abuse.
Author Grecu, Anca M.
Dave, Dhaval M.
Saffer, Henry
Author_xml – sequence: 1
  givenname: Anca M.
  surname: Grecu
  fullname: Grecu, Anca M.
– sequence: 2
  givenname: Dhaval M.
  surname: Dave
  fullname: Dave, Dhaval M.
– sequence: 3
  givenname: Henry
  surname: Saffer
  fullname: Saffer, Henry
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30572414$$D View this record in MEDLINE/PubMed
BookMark eNp1kD1PwzAQhi1URD9g4A-gSEwMaW0nju0xKp9SKyoEs-U4TpWqsYPdCOXfY0hhAt1wwz333umZgpGxRgNwieAcQYgXrWzmGEPOTsAEEQzjLGNsBCYQ0yxmNOFjMPV-ByEkkKMzME4goThF6QS8rKUp5cG6PsqV0t5HG6e9cnV7qK2Jbl23jdbW1IGozTYM7dbJxkdh6w8yLzqvz8FpJfdeXxz7DLzd370uH-PV88PTMl_FKsWIxZwqXiHGdEnSjBZQZ7TklCCuSkYlkuE9TrKqUoUiuJApr0rGeElRpRXXpEhm4HrIbZ1977Q_iJ3tnAknBcYoCYUoCtTNQClnvXe6Eq2rG-l6gaD4sieCPfFtL7BXx8SuaHT5S_7oCsBiAD7qve7_TxKbfD1EfgJB23r0
CitedBy_id crossref_primary_10_1016_j_annemergmed_2022_11_003
crossref_primary_10_1086_722981
crossref_primary_10_1007_s11606_022_07793_x
crossref_primary_10_1016_j_japh_2020_07_002
crossref_primary_10_1186_s13012_020_01071_2
crossref_primary_10_1002_hec_3922
crossref_primary_10_1002_hec_4812
crossref_primary_10_1016_j_jhealeco_2020_102408
crossref_primary_10_1093_jeea_jvae034
crossref_primary_10_1111_jori_12376
crossref_primary_10_1093_epirev_mxaa002
crossref_primary_10_1016_j_socscimed_2020_113406
crossref_primary_10_1111_dar_13712
crossref_primary_10_1016_j_dadr_2022_100042
crossref_primary_10_1097_ADM_0000000000001187
crossref_primary_10_1007_s40258_020_00622_4
crossref_primary_10_1016_j_ssmph_2020_100679
crossref_primary_10_1111_1475_6773_13119
crossref_primary_10_2139_ssrn_4098995
crossref_primary_10_1002_hec_4020
crossref_primary_10_1016_j_micpro_2020_103060
crossref_primary_10_1016_j_jhealeco_2023_102772
crossref_primary_10_1111_dar_12959
crossref_primary_10_1002_hec_4589
crossref_primary_10_1377_hlthaff_2022_00859
crossref_primary_10_7759_cureus_31027
crossref_primary_10_1016_j_labeco_2023_102358
crossref_primary_10_1016_j_drugalcdep_2021_109232
crossref_primary_10_2139_ssrn_3214825
crossref_primary_10_1080_10920277_2022_2106576
crossref_primary_10_1111_coep_12586
crossref_primary_10_2139_ssrn_3192703
crossref_primary_10_1016_j_drugalcdep_2019_107754
crossref_primary_10_1016_j_japh_2021_04_019
crossref_primary_10_1016_j_jpubeco_2023_104980
crossref_primary_10_1111_1475_6773_13604
crossref_primary_10_2139_ssrn_4114797
crossref_primary_10_2139_ssrn_3445962
crossref_primary_10_1016_j_drugalcdep_2020_108328
crossref_primary_10_1016_j_drugalcdep_2020_108405
crossref_primary_10_1080_15563650_2023_2181092
crossref_primary_10_2139_ssrn_4160493
crossref_primary_10_1021_acssensors_3c02069
crossref_primary_10_1177_1077558721994994
crossref_primary_10_1002_hec_4633
crossref_primary_10_1371_journal_pmed_1003272
crossref_primary_10_1016_j_japh_2019_09_016
crossref_primary_10_2139_ssrn_3865764
crossref_primary_10_1002_soej_12481
crossref_primary_10_1016_j_drugalcdep_2023_109887
crossref_primary_10_1007_s40429_021_00397_1
crossref_primary_10_1016_j_drugalcdep_2019_03_034
crossref_primary_10_1093_haschl_qxad067
crossref_primary_10_1177_00220426231179211
crossref_primary_10_1257_aer_20210357
crossref_primary_10_1016_j_jval_2020_12_002
crossref_primary_10_1186_s12889_023_16256_9
crossref_primary_10_1080_08897077_2019_1695707
crossref_primary_10_1057_s41271_021_00275_0
crossref_primary_10_2139_ssrn_4093503
crossref_primary_10_1002_hec_4446
crossref_primary_10_1515_bejeap_2020_0253
crossref_primary_10_1111_coep_12607
crossref_primary_10_1016_j_drugalcdep_2020_108460
crossref_primary_10_1177_00027162211033833
crossref_primary_10_1111_coep_12523
crossref_primary_10_1007_s11469_022_00823_z
crossref_primary_10_1016_j_urology_2020_05_096
crossref_primary_10_3390_jcm8122143
crossref_primary_10_1016_j_jhealeco_2019_01_001
crossref_primary_10_1093_pm_pnaa412
crossref_primary_10_2139_ssrn_4266020
crossref_primary_10_1016_j_drugalcdep_2020_108107
crossref_primary_10_1177_00027162221149285
crossref_primary_10_1016_j_jpubeco_2022_104784
crossref_primary_10_1542_peds_2020_039743
crossref_primary_10_1111_dar_13431
crossref_primary_10_1186_s12916_024_03287_1
crossref_primary_10_1016_j_jhealeco_2021_102542
crossref_primary_10_1016_j_ypmed_2021_106846
crossref_primary_10_1016_j_irle_2023_106136
crossref_primary_10_2139_ssrn_3596507
Cites_doi 10.1037/e597562007-001
10.3109/01612840.2011.654046
10.1073/pnas.1518393112
10.1016/j.jhealeco.2005.08.003
10.1097/MLR.0000000000000625
10.1016/j.drugalcdep.2014.10.001
10.1001/jamainternmed.2015.3931
10.1086/250026
10.2307/j.ctvcm4j72
10.1001/jamainternmed.2014.4005
10.36076/ppj.2010/13/401
10.1111/j.1526-4637.2009.00603.x
10.1016/j.jue.2018.01.007
10.1016/j.jhealeco.2017.07.009
10.1111/j.1749-6632.2009.05275.x
10.2139/ssrn.3037875
10.1002/hec.1577
10.2105/AJPH.2016.303627
10.1111/j.1526-4637.2012.01327.x
10.1111/j.1746-1561.1993.tb06150.x
10.3386/w23148
10.1002/pam.21804
10.15288/jsa.2001.62.32
10.1111/j.1526-4637.2011.01062.x
10.1136/bmj.g1393
10.1016/j.drugalcdep.2012.06.027
10.3810/pgm.2014.09.2801
10.1155/2011/948789
10.1016/j.addbeh.2017.01.011
10.1016/j.drugpo.2012.10.004
10.1001/jamainternmed.2013.12809
10.1016/j.jhealeco.2017.12.007
10.3200/JACH.53.6.253-262
10.1097/00002508-200207001-00005
10.36076/ppj.2011/14/E103
10.1056/NEJMsa1514387
10.1177/003335491412900207
10.3109/10826084.2015.1027929
10.1001/jama.2014.18514
10.1016/j.jpain.2012.07.007
10.15585/mmwr.mm655051e1
10.4137/SART.S2345
ContentType Journal Article
Copyright 2018 by the Association for Public Policy Analysis and Management
2019 by the Association for Public Policy Analysis and Management
Copyright_xml – notice: 2018 by the Association for Public Policy Analysis and Management
– notice: 2019 by the Association for Public Policy Analysis and Management
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TQ
8BJ
DHY
DON
FQK
JBE
K9.
DOI 10.1002/pam.22098
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PAIS Index
International Bibliography of the Social Sciences (IBSS)
PAIS International
PAIS International (Ovid)
International Bibliography of the Social Sciences
International Bibliography of the Social Sciences
ProQuest Health & Medical Complete (Alumni)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
International Bibliography of the Social Sciences (IBSS)
ProQuest Health & Medical Complete (Alumni)
PAIS International
DatabaseTitleList
International Bibliography of the Social Sciences (IBSS)
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Government
Social Sciences (General)
Political Science
EISSN 1520-6688
EndPage 209
ExternalDocumentID 10_1002_pam_22098
30572414
PAM22098
Genre article
Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: AHRQ HHS
  grantid: R03 HS025014
– fundername: AHRQ HHS
  grantid: 1 R03 HS025014-01
GroupedDBID ---
-ET
-~X
.3N
.GA
.Y3
0-V
05W
0R~
10A
1L6
1OB
1OC
1OL
29L
2AX
2FS
31~
33P
3V.
3WU
4.4
44B
4ZD
50Y
50Z
51W
51Y
52M
52O
52Q
52S
52T
52U
52W
5GY
5VS
66C
702
7PT
7WY
7X7
8-0
8-1
8-3
8-4
8-5
85S
88E
8FI
8FJ
8FL
8G5
8H~
8R4
8R5
8UM
8VB
930
A04
AABNI
AAESR
AAFWJ
AAHHS
AAIKC
AAMNW
AAONW
AAOUF
AASGY
AAXRX
AAYOK
AAZKR
ABBHK
ABCQN
ABCUV
ABEFU
ABEML
ABIJN
ABIVO
ABJNI
ABKTN
ABKVW
ABLWH
ABPPZ
ABPVW
ABQIJ
ABSOO
ABUWG
ABXSQ
ABYRZ
ABYYQ
ACAHQ
ACBKW
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACHQT
ACIOK
ACNCT
ACPOU
ACREJ
ACSCC
ACVFL
ACXQS
ADACV
ADBBV
ADEMA
ADEOM
ADEPB
ADGDI
ADIZJ
ADKYN
ADMGS
ADNFJ
ADULT
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AEQDE
AEUPB
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFKFF
AFKRA
AFPWT
AFZJQ
AHAJD
AHBTC
AIAGR
AIFKG
AIURR
AIWBW
AJBDE
AJPNJ
AKNXY
AKVCP
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALPBS
ALSLI
ALUQN
AMBMR
AMYDB
AQSKT
ARALO
ASPBG
ASTYK
AVWKF
AZBYB
AZFZN
AZQEC
AZVAB
BAFTC
BDRZF
BENPR
BEZIV
BFHJK
BKOMP
BMKGK
BMXJE
BNVMJ
BPHCQ
BQESF
BROTX
BRXPI
BVXVI
BY8
CBXGM
CCPQU
CHNMF
CJNVE
CS3
D-C
D-D
DCZOG
DPSOV
DPXWK
DR2
DRFUL
DRSSH
DU5
DWQXO
EBD
EBO
EBS
EBU
ECVKH
EJD
EMOBN
F00
F01
FEDTE
FRNLG
FYUFA
G-S
G.N
G50
G8K
GENNL
GNP
GNUQQ
GODZA
GROUPED_ABI_INFORM_ARCHIVE
GROUPED_ABI_INFORM_COMPLETE
GROUPED_ABI_INFORM_RESEARCH
GUQSH
HBH
HECYW
HF~
HGD
HGLYW
HHY
HMCUK
HVGLF
HYQOX
HZ~
IPSME
IX1
J0M
JAAYA
JAV
JBMMH
JBU
JBZCM
JENOY
JHFFW
JKQEH
JLEZI
JLXEF
JPC
JPL
JPPEU
JSODD
JST
K1G
K60
K6~
KC-
KQQ
LATKE
LAW
LC2
LC4
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LPU
LUTES
LW6
LYRES
M0C
M0P
M1P
M1Q
M2L
M2O
M2R
M55
MEWTI
MK4
MRFUL
MRSSH
MSFUL
MSSSH
MVM
MXFUL
MXSSH
N04
N06
N9A
NEJ
NF~
NHB
NNB
O-F
O66
O9-
P2P
P2W
P2Y
P4C
PALCI
PQBIZ
PQBZA
PQEDU
PQQKQ
PROAC
PSQYO
Q.N
Q11
Q2X
Q5E
QB0
QRW
QWB
R.K
RIWAO
RJQFR
RNS
ROL
RWI
RX1
RXW
SA0
SAMSI
SUPJJ
SV3
TAE
TH9
TN5
UB1
UKHRP
V2E
V8K
VQA
VQP
W8V
W99
WBKPD
WEBCB
WH7
WHG
WIB
WIH
WII
WOHZO
WQZ
WRC
WSUWO
WWB
WXSBR
XG1
XPP
XSW
XV2
YQT
ZCA
ZL0
ZUP
ZZTAW
~IA
~P2
~P3
~WP
ACXME
AFDAS
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TQ
8BJ
DHY
DON
FQK
JBE
K9.
ID FETCH-LOGICAL-c4218-97c9f188ed5467b0e67d97519cd87a1a414956ffcbc52ba49fd889d71fec9e5b3
IEDL.DBID DR2
ISSN 0276-8739
IngestDate Fri Sep 13 06:54:29 EDT 2024
Fri Aug 23 01:17:11 EDT 2024
Thu May 23 23:35:56 EDT 2024
Sat Aug 24 00:53:43 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4218-97c9f188ed5467b0e67d97519cd87a1a414956ffcbc52ba49fd889d71fec9e5b3
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pam.22098
PMID 30572414
PQID 2213131171
PQPubID 48213
PageCount 29
ParticipantIDs proquest_journals_2213131171
crossref_primary_10_1002_pam_22098
pubmed_primary_30572414
wiley_primary_10_1002_pam_22098_PAM22098
PublicationCentury 2000
PublicationDate Winter 2019
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – year: 2019
  text: Winter 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of policy analysis and management
PublicationTitleAlternate J Policy Anal Manage
PublicationYear 2019
Publisher Wiley Periodicals Inc
Publisher_xml – name: Wiley Periodicals Inc
References 2015; 34
2002; 18
2010; 13
2017; 69
2011
2013; 24
2015; 50
2013; 127
2018; 104
1993; 63
2016; 54
2008
2006
2005
2004
2011; 12
2011; 14
2012; 13
2014; 174
2012; 33
2001; 62
2014; 129
2014; 348
2009; 10
2015; 313
2015; 112
2006; 25
2015; 175
2017; 56
2011; 20
2016; 375
2005; 53
2017
2016
2015
1998; 106
2014
2009; 3
2010; 1187
2004; 119
2014; 126
2014; 145
2018; 58
2017; 107
e_1_2_9_31_1
e_1_2_9_52_1
e_1_2_9_50_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_54_1
e_1_2_9_14_1
e_1_2_9_39_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_20_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_8_1
e_1_2_9_4_1
e_1_2_9_2_1
Bertrand M. (e_1_2_9_6_1) 2004; 119
e_1_2_9_26_1
e_1_2_9_49_1
Manchikanti L. (e_1_2_9_28_1) 2011; 14
e_1_2_9_47_1
e_1_2_9_30_1
e_1_2_9_53_1
e_1_2_9_51_1
e_1_2_9_11_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_40_1
e_1_2_9_21_1
e_1_2_9_46_1
e_1_2_9_23_1
e_1_2_9_44_1
e_1_2_9_7_1
e_1_2_9_5_1
e_1_2_9_3_1
e_1_2_9_9_1
e_1_2_9_25_1
National Center on Addiction and Substance Abuse (e_1_2_9_34_1) 2005
e_1_2_9_27_1
e_1_2_9_48_1
e_1_2_9_29_1
References_xml – year: 2011
– volume: 10
  start-page: 537
  year: 2009
  end-page: 548
  article-title: Prescription opioid abuse and diversion in an urban community: The results of an ultrarapid assessment
  publication-title: Pain Medicine
– volume: 107
  start-page: 430
  year: 2017
  end-page: 432
  article-title: Recent increases in cocaine‐related overdose deaths and the role of opioids
  publication-title: American Journal of Public Health
– volume: 127
  start-page: 156
  year: 2013
  end-page: 162
  article-title: Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents
  publication-title: Drug and Alcohol Dependence
– volume: 53
  start-page: 253
  year: 2005
  end-page: 262
  article-title: Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample
  publication-title: Journal of American College Health
– year: 2005
– volume: 18
  start-page: S39
  year: 2002
  end-page: S51
  article-title: Assessment of efficacy of long‐term opioid therapy in pain patients with substance abuse potential
  publication-title: The Clinical Journal of Pain
– volume: 34
  start-page: 7
  year: 2015
  end-page: 31
  article-title: Assessing the effects of medical marijuana laws on marijuana use: The devil is in the details
  publication-title: Journal of Policy Analysis and Management
– volume: 63
  start-page: 302
  year: 1993
  end-page: 306
  article-title: Cigarette smoking as a predictor of alcohol and other drug use by children and adolescents: Evidence of the “gateway drug effect.”
  publication-title: Journal of School Health
– volume: 375
  start-page: 44
  year: 2016
  end-page: 53
  article-title: State legal restrictions and prescription‐opioid use among disabled adults
  publication-title: New England Journal of Medicine
– volume: 25
  start-page: 311
  year: 2006
  end-page: 333
  article-title: The effects of cocaine and heroin price on drug‐related emergency department visits
  publication-title: Journal of Health Economics
– volume: 175
  start-page: 1642
  year: 2015
  end-page: 1649
  article-title: Effect of Florida's prescription drug monitoring program and pill mill laws on opioid prescribing and use
  publication-title: JAMA Internal Medicine
– volume: 56
  start-page: 222
  year: 2017
  end-page: 233
  article-title: Macroeconomic conditions and opioid abuse
  publication-title: Journal of Health Economics
– volume: 13
  start-page: 434
  year: 2012
  end-page: 442
  article-title: Do prescription monitoring programs impact state trends in opioid abuse/misuse?
  publication-title: Pain Medicine
– volume: 129
  start-page: 139
  year: 2014
  end-page: 147
  article-title: Prescription drug monitoring and dispensing of prescription opioids
  publication-title: Public Health Reports
– volume: 106
  start-page: 667
  year: 1998
  end-page: 705
  article-title: The effect of state policies on the location of manufacturing: Evidence from state borders
  publication-title: Journal of Political Economy
– volume: 13
  start-page: 401
  year: 2010
  end-page: 435
  article-title: Therapeutic use, abuse, and nonmedical use of opioids: A ten‐year perspective
  publication-title: Pain Physician
– volume: 126
  start-page: 5
  year: 2014
  article-title: The potential for misuse and abuse of medications in ADHD: A review
  publication-title: Postgraduate Medicine
– volume: 13
  start-page: 988
  year: 2012
  end-page: 996
  article-title: Geographic variation in opioid prescribing in the U.S.
  publication-title: Journal of Pain
– year: 2016
– volume: 1187
  start-page: 184
  year: 2010
  end-page: 207
  article-title: Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment
  publication-title: Annals of the New York Academy of Sciences
– year: 2014
– volume: 3
  start-page: SART
  year: 2009
  end-page: S2345
  article-title: Prescription opioid usage and abuse relationships: An evaluation of state prescription drug monitoring program efficacy
  publication-title: Substance Abuse: Research and Treatment
– volume: 174
  start-page: 1668
  year: 2014
  end-page: 1673
  article-title: Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010
  publication-title: JAMA internal medicine
– volume: 12
  start-page: 747
  year: 2011
  end-page: 754
  article-title: Prescription drug monitoring programs and death rates from drug overdose
  publication-title: Pain Medicine
– volume: 50
  start-page: 1660
  year: 2015
  end-page: 1667
  article-title: Demographic trends of adults in New York City opioid treatment programs—An aging population
  publication-title: Substance use & misuse
– volume: 58
  start-page: 29
  year: 2018
  end-page: 42
  article-title: Do medical marijuana laws reduce addictions and deaths related to pain killers?
  publication-title: Journal of Health Economics
– volume: 348
  start-page: g1393
  year: 2014
  article-title: Opioid prescribing by multiple providers in Medicare: Retrospective observational study of insurance claims
  publication-title: The BMJ
– year: 2008
– volume: 33
  start-page: 319
  year: 2012
  end-page: 328
  article-title: Prescription drug monitoring programs, a response to doctor shopping: Purpose, effectiveness, and directions for future research
  publication-title: Issues in Mental Health Nursing
– volume: 20
  start-page: 161
  year: 2011
  end-page: 183
  article-title: Mental health parity legislation, cost‐sharing, and substance‐abuse treatment admissions
  publication-title: Health Economics
– year: 2006
– volume: 24
  start-page: 142
  year: 2013
  end-page: 149
  article-title: Patterns of cocaine and opioid co‐use and polyroutes of administration among street‐based cocaine users in Montréal, Canada
  publication-title: International Journal of Drug Policy
– year: 2004
– volume: 69
  start-page: 65
  year: 2017
  end-page: 77
  article-title: Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health
  publication-title: Addictive Behaviors
– volume: 62
  start-page: 32
  year: 2001
  end-page: 43
  article-title: Social influence processes and college student drinking: The mediational role of alcohol outcome expectancies
  publication-title: Journal of Studies on Alcohol
– year: 2011
  article-title: Distance traveled and cross‐state commuting to opioid treatment programs in the United States
  publication-title: Journal of Environmental and Public Health
– volume: 54
  start-page: 901
  year: 2016
  end-page: 906
  article-title: The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013
  publication-title: Medical Care
– volume: 313
  start-page: 891
  year: 2015
  end-page: 892
  article-title: Mandatory use of prescription drug monitoring programs
  publication-title: Journal of the American Medical Association
– volume: 119
  start-page: 249
  year: 2004
  end-page: 275
  publication-title: How much should we trust differences‐in‐differences estimates? The Quarterly Journal of Economics
– volume: 104
  start-page: 124
  year: 2018
  end-page: 133
  article-title: Substance abuse treatment centers and local crime
  publication-title: Journal of Urban Economics
– volume: 112
  start-page: 15078
  year: 2015
  end-page: 15083
  article-title: Rising morbidity and mortality in midlife among white non‐Hispanic Americans in the 21st century
  publication-title: Proceedings of the National Academy of the Sciences of the United States of America
– volume: 14
  start-page: E103
  year: 2011
  end-page: E117
  article-title: Breakthrough pain in chronic non‐cancer pain: Fact, fiction, or abuse
  publication-title: Pain Physician
– year: 2017
– volume: 174
  start-page: 802
  year: 2014
  end-page: 803
  article-title: Sources of prescription opioid pain relievers by frequency of past‐year nonmedical use: United States, 2008–2011
  publication-title: JAMA Internal Medicine
– year: 2015
– volume: 145
  start-page: 34
  year: 2014
  end-page: 47
  article-title: What we know, and don't know, about the impact of state policy and systems‐level interventions on prescription drug overdose
  publication-title: Drug and Alcohol Dependence
– ident: e_1_2_9_48_1
– ident: e_1_2_9_49_1
  doi: 10.1037/e597562007-001
– volume-title: Under the counter: The diversion and abuse of controlled prescription drugs in the U.S.
  year: 2005
  ident: e_1_2_9_34_1
  contributor:
    fullname: National Center on Addiction and Substance Abuse
– ident: e_1_2_9_54_1
  doi: 10.3109/01612840.2011.654046
– ident: e_1_2_9_3_1
– ident: e_1_2_9_25_1
– ident: e_1_2_9_11_1
  doi: 10.1073/pnas.1518393112
– volume: 119
  start-page: 249
  year: 2004
  ident: e_1_2_9_6_1
  publication-title: How much should we trust differences‐in‐differences estimates? The Quarterly Journal of Economics
  contributor:
    fullname: Bertrand M.
– ident: e_1_2_9_14_1
  doi: 10.1016/j.jhealeco.2005.08.003
– ident: e_1_2_9_16_1
  doi: 10.1097/MLR.0000000000000625
– ident: e_1_2_9_17_1
  doi: 10.1016/j.drugalcdep.2014.10.001
– ident: e_1_2_9_47_1
  doi: 10.1001/jamainternmed.2015.3931
– ident: e_1_2_9_21_1
  doi: 10.1086/250026
– ident: e_1_2_9_4_1
  doi: 10.2307/j.ctvcm4j72
– ident: e_1_2_9_5_1
  doi: 10.1001/jamainternmed.2014.4005
– ident: e_1_2_9_29_1
  doi: 10.36076/ppj.2010/13/401
– ident: e_1_2_9_35_1
– ident: e_1_2_9_27_1
– ident: e_1_2_9_22_1
  doi: 10.1111/j.1526-4637.2009.00603.x
– ident: e_1_2_9_8_1
  doi: 10.1016/j.jue.2018.01.007
– ident: e_1_2_9_20_1
  doi: 10.1016/j.jhealeco.2017.07.009
– ident: e_1_2_9_55_1
  doi: 10.1111/j.1749-6632.2009.05275.x
– ident: e_1_2_9_7_1
  doi: 10.2139/ssrn.3037875
– ident: e_1_2_9_15_1
  doi: 10.1002/hec.1577
– ident: e_1_2_9_31_1
  doi: 10.2105/AJPH.2016.303627
– ident: e_1_2_9_41_1
– ident: e_1_2_9_30_1
– ident: e_1_2_9_42_1
  doi: 10.1111/j.1526-4637.2012.01327.x
– ident: e_1_2_9_51_1
  doi: 10.1111/j.1746-1561.1993.tb06150.x
– ident: e_1_2_9_10_1
  doi: 10.3386/w23148
– ident: e_1_2_9_38_1
  doi: 10.1002/pam.21804
– ident: e_1_2_9_53_1
  doi: 10.15288/jsa.2001.62.32
– ident: e_1_2_9_39_1
  doi: 10.1111/j.1526-4637.2011.01062.x
– ident: e_1_2_9_23_1
  doi: 10.1136/bmj.g1393
– ident: e_1_2_9_52_1
  doi: 10.1016/j.drugalcdep.2012.06.027
– ident: e_1_2_9_36_1
– ident: e_1_2_9_13_1
  doi: 10.3810/pgm.2014.09.2801
– ident: e_1_2_9_44_1
  doi: 10.1155/2011/948789
– ident: e_1_2_9_2_1
  doi: 10.1016/j.addbeh.2017.01.011
– ident: e_1_2_9_45_1
  doi: 10.1016/j.drugpo.2012.10.004
– ident: e_1_2_9_24_1
  doi: 10.1001/jamainternmed.2013.12809
– ident: e_1_2_9_40_1
  doi: 10.1016/j.jhealeco.2017.12.007
– ident: e_1_2_9_50_1
  doi: 10.3200/JACH.53.6.253-262
– ident: e_1_2_9_37_1
  doi: 10.1097/00002508-200207001-00005
– volume: 14
  start-page: E103
  year: 2011
  ident: e_1_2_9_28_1
  article-title: Breakthrough pain in chronic non‐cancer pain: Fact, fiction, or abuse
  publication-title: Pain Physician
  doi: 10.36076/ppj.2011/14/E103
  contributor:
    fullname: Manchikanti L.
– ident: e_1_2_9_12_1
– ident: e_1_2_9_33_1
  doi: 10.1056/NEJMsa1514387
– ident: e_1_2_9_26_1
– ident: e_1_2_9_9_1
  doi: 10.1177/003335491412900207
– ident: e_1_2_9_19_1
  doi: 10.3109/10826084.2015.1027929
– ident: e_1_2_9_18_1
  doi: 10.1001/jama.2014.18514
– ident: e_1_2_9_32_1
  doi: 10.1016/j.jpain.2012.07.007
– ident: e_1_2_9_46_1
  doi: 10.15585/mmwr.mm655051e1
– ident: e_1_2_9_43_1
  doi: 10.4137/SART.S2345
SSID ssj0005091
Score 2.5362048
Snippet Despite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects...
Abstract Despite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 181
SubjectTerms Access
Adolescent
Adult
Analgesics, Opioid
Cannabis
Cocaine
Drug abuse
Drug Overdose - mortality
Heroin
Humans
Illicit Drugs
Mandatory Programs
Marijuana
Middle Aged
Mortality
Narcotics
Opioids
Patient admissions
Policy making
Prescribing
Prescription drug abuse
Prescription Drug Diversion - prevention & control
Prescription Drug Misuse - prevention & control
prescription drug monitoring programs
Prescription Drug Monitoring Programs - statistics & numerical data
Prescription drugs
Robustness
Rx drugs
State Government
Substance abuse
Substance abuse treatment
Substance-Related Disorders - epidemiology
Therapeutic drug monitoring
United States
Young Adult
Young adults
Title Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpam.22098
https://www.ncbi.nlm.nih.gov/pubmed/30572414
https://www.proquest.com/docview/2213131171/abstract/
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFH-MnXbROb-qU4p4mIdu_UibBk9DHUOYyHCwg1D60tSDOMe6XfzrzUe7MT9AvJU2CW1e3i-_vL78AnDJ3RiVEpjDkOQOiVE4SGLh-EgDLmjKMVULxdFDNJyQ-2k4rcF1tRfG6EOsA27KMzReKwdPsehtREPn6VvX912mNvoqIT1FiMYb6Sg1Eer4Co2kxwesUhVy_d665vZc9I1gbvNVPeEMduG5elWTZ_LaXS2xyz--qDj-81uasFMSUbtvRs4e1MSsBY3N0bstaJa5cbJUiQAtsMx23upGYXdK3eqrfRiPVFRC_bS3-_oYRlvld1SoZN8uVi-2gRAVS5QPdWZYYctaP5Ts46oQBzAZ3D3dDJ3yyAaHE0kWHEY5y704FlkoERhdEdGMUckSeRbT1EuJXpDlOUce-pgSlmdxzDLq5YIzEWJwCPXZ-0wcgy2Ih16Y8zRDRpBFLOMoAQkDOejcDCMLLirjJXOjzJEYDWY_kf2Z6P60oF2ZNSmds5BPvECpDFHPgiNj6nULEv6oJDXEgo422O9NJ4_9kb44-XvRU2hIwsVMCKcN9eViJc4kqVniuR69nwdQ8x4
link.rule.ids 315,786,790,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2xHODCUrawRogDHNJmcWJb4lIBVYEWIQQSFxRlHIcDolRdLnw9XpJWbBLiFsWLYo9n_GYyfgY4Ej5DzQTmcSSFRxhKDwmTXog0EpJmAjPtKHZvkvYDuXqMH2fgtDoLY_khJgE3rRnGXmsF1wHpxpQ1tJ-91sPQ52wW5pW6x8ahupuSR-mt0ERYaKJ0PuIVr5AfNiZNP-9G3yDmZ8RqtpzWMjxVH2szTV7q4xHWxfsXHsf_jmYFlkos6jbt4lmFGdmrweL09t0arJTpcapWaQRq4NgTvdWLoXtcUlefrMFdVwcm9H97t2luYnR1ikdlmNzzwfjZtVZEhxNVoUkOG7qq1Q81mzgeynV4aF3cn7W98tYGTxCFFzxOBS8CxmQeK6mgLxOac6qAosgZzYKMGJ-sKASKOMSM8CJnjOc0KKTgMsZoA-Z6bz25Ba4kAQZxIbIcOUGe8FygskkYqXXn55g4cFhJL-1bco7U0jCHqZrP1MynA7uVXNNSP4eqJIg00RANHNi0sp70oCwgVbiGOHBsJPZ71-lts2setv9e9QAW2vfdTtq5vLnegUWFv7iN6OzC3GgwlnsK44xw3yzlD0c990A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT-MwFH5iQEJcoJSZIVAgQhyYQ9osTmyLU0Wp2IoQAonDSFGe7cwBUSraXvj1eElasUkjblG8KPZb_Pnl-TPAgQgZGiawgCMpA8JQBUiYCmKkiVC0EFiYjeLgKju9I-f36f0CHNVnYRw_xCzgZizD-mtj4CNZduakoaPisR3HIWc_YIlkSWxUuncz544yK6ENsNBMm3zCa1qhMO7Mmr5djD4gzLeA1a44_TX4W3-rSzR5aE8n2BYv72gcvzmYBqxWSNTvOtVZhwU1bMLK_O7dJjSq5Dhdq3IBTfDced76xdg_rIir_2zAzcCEJcxfe79r72H0TYJH7Zb83vP0n-98iAkm6kKbGjb2datPanZxOlY_4a5_cnt8GlR3NgSCaLQQcCp4GTGmZKpdMIYqo5JTDROFZLSICmJ3ZGUpUKQxFoSXkjEuaVQqwVWKyS9YHD4N1Sb4ikQYpaUoJHKCPONSoPZImGitCyVmHuzXwstHjpojdyTMca7nM7fz6UGrFmteWedYl0SJoRmikQe_nahnPWj_RzWqIR4cWoF93XV-3R3Yh63_r7oHy9e9fn55dnWxDSsafHEXzmnB4uR5qnY0wJngrlXkV2-I9e8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mandatory+Access+Prescription+Drug+Monitoring+Programs+and+Prescription+Drug+Abuse&rft.jtitle=Journal+of+policy+analysis+and+management&rft.au=Grecu%2C+Anca+M&rft.au=Dave%2C+Dhaval+M&rft.au=Saffer%2C+Henry&rft.date=2019-01-01&rft.pub=Wiley+Periodicals+Inc&rft.issn=0276-8739&rft.eissn=1520-6688&rft.volume=38&rft.issue=1&rft.spage=181&rft.epage=209&rft_id=info:doi/10.1002%2Fpam.22098&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0276-8739&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0276-8739&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0276-8739&client=summon